Quadrivalent inactivated influenza vaccine - Fluart Innovative Vaccines
Alternative Names: 4Fluart ID - Fluart Innovative VaccinesLatest Information Update: 03 Nov 2021
At a glance
- Originator Fluart Innovative Vaccines
- Developer Fluart Innovative Vaccines; MegaPharm Ltd
- Class Antivirals; Influenza virus vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 09 Mar 2021 Discontinued - Phase-I for Influenza virus infections (Prevention, In volunteers) in Hungary (Intradermal) (Fluart Innovative Vaccines website, March 2021)
- 28 Feb 2021 No recent reports of development identified for phase-I development in Influenza-virus-infections(Prevention, In volunteers) in Hungary (Intradermal, Injection)
- 31 Jan 2018 Phase-I clinical trials in Influenza virus infections (Prevention, In volunteers) in Hungary (Intradermal) (NCT03448705)